ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension

This study has been completed.

Sponsored by: Alcon Research
Information provided by: Alcon Research
ClinicalTrials.gov Identifier: NCT00314158
  Purpose

The purpose of this study is to determine whether a glaucoma therapy is safe and effective in treating patients with open-angle glaucoma or ocular hypertension.


Condition Intervention Phase
Open-Angle Glaucoma
Ocular Hypertension
Drug: Brinzolamide 1%/Timolol 0.5%, Brinzolamide 1%, Timolol 0.5%
Phase III

Genetics Home Reference related topics:   early-onset glaucoma   

MedlinePlus related topics:   Glaucoma    High Blood Pressure   

ChemIDplus related topics:   Azopt    Timolol    Timolol maleate   

U.S. FDA Resources

Study Type:   Interventional
Study Design:   Treatment, Randomized, Double-Blind, Active Control, Parallel Assignment, Safety/Efficacy Study
  Eligibility
Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Criteria

Inclusion Criteria:

  • Over 18 with open-angle glaucoma

Exclusion Criteria:

  • Under 18
  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00314158

Locations
United States, Texas
United States Investigative Sites    
      Fort Worth, Texas, United States, 76134

Sponsors and Collaborators
Alcon Research
  More Information


Study ID Numbers:   C-05-24
First Received:   April 10, 2006
Last Updated:   February 29, 2008
ClinicalTrials.gov Identifier:   NCT00314158
Health Authority:   United States: Food and Drug Administration

Study placed in the following topic categories:
Brinzolamide
Glaucoma
Eye Diseases
Glaucoma, Open-Angle
Vascular Diseases
Timolol
Hypertension
Ocular Hypertension

Additional relevant MeSH terms:
Neurotransmitter Agents
Adrenergic Agents
Molecular Mechanisms of Pharmacological Action
Physiological Effects of Drugs
Enzyme Inhibitors
Cardiovascular Agents
Antihypertensive Agents
Pharmacologic Actions
Carbonic Anhydrase Inhibitors
Therapeutic Uses
Adrenergic beta-Antagonists
Cardiovascular Diseases
Adrenergic Antagonists
Anti-Arrhythmia Agents

ClinicalTrials.gov processed this record on October 10, 2008




Links to all studies - primarily for crawlers